Medincell SA (MEDCL) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.465x

Based on the latest financial reports, Medincell SA (MEDCL) has a cash flow conversion efficiency ratio of 0.465x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-14.25 Million ≈ $-16.66 Million USD) by net assets (€-30.63 Million ≈ $-35.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Medincell SA liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Medincell SA - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Medincell SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Medincell SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medincell SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Yunnan Hongxiang Yixintang SHE:002727	0.069x
Lemon Tree Hotels Limited NSE:LEMONTREE	0.113x
Shenzhen Anche Technologies Co Ltd SHE:300572	0.006x
Yulon Motor Co Ltd TW:2201	0.052x
Hexatronic Group AB ST:HTRO	0.008x
Sinoseal Holding Co Ltd SHE:300470	0.035x
Cathay Real Estate Development Co Ltd TW:2501	0.003x
Zhejiang Hailide New Material Co Ltd SHE:002206	0.065x

Annual Cash Flow Conversion Efficiency for Medincell SA (2016–2025)

The table below shows the annual cash flow conversion efficiency of Medincell SA from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Medincell SA (MEDCL) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	€-16.37 Million ≈ $-19.13 Million	€19.46 Million ≈ $22.76 Million	-1.189x	-507.24%
2024-03-31	€-40.82 Million ≈ $-47.73 Million	€-11.92 Million ≈ $-13.94 Million	0.292x	-41.20%
2023-03-31	€-42.29 Million ≈ $-49.45 Million	€-21.00 Million ≈ $-24.56 Million	0.497x	-68.91%
2022-03-31	€-13.37 Million ≈ $-15.63 Million	€-21.36 Million ≈ $-24.97 Million	1.598x	+217.37%
2021-03-31	€8.92 Million ≈ $10.42 Million	€-12.14 Million ≈ $-14.19 Million	-1.361x	-273.23%
2020-03-31	€-15.96 Million ≈ $-18.66 Million	€-12.54 Million ≈ $-14.66 Million	0.786x	+130.79%
2019-03-31	€6.24 Million ≈ $7.30 Million	€-15.93 Million ≈ $-18.63 Million	-2.552x	-652.58%
2018-03-31	€-11.75 Million ≈ $-13.74 Million	€-5.43 Million ≈ $-6.34 Million	0.462x	-68.86%
2017-03-31	€-2.29 Million ≈ $-2.67 Million	€-3.39 Million ≈ $-3.97 Million	1.483x	+2787.40%
2016-03-31	€1.32 Million ≈ $1.55 Million	€68.00K ≈ $79.50K	0.051x	--

About Medincell SA

PA:MEDCL France Biotechnology

Market Cap

$1.18 Billion

€1.01 Billion EUR

Market Cap Rank

#9364 Global

#149 in France

Share Price

€28.02

Change (1 day)

+0.72%

52-Week Range

€15.63 - €38.46

All Time High

€38.46